Leukotriene A4 Hydrolase
From Proteopedia
(Difference between revisions)
(30 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | + | <StructureSection load='' size='350' side='right' caption='Human leukotriene A4 Hydrolase complex with bestatin, acetate, imidazole, Yb+3 (green) and Zn+2 (grey) ions (PDB entry [[1hs6]])' scene='43/433034/Cv/1'> | |
- | + | == Function == | |
+ | [[Leukotriene A4 Hydrolase]] (LTA4H) is an aminopeptidase which converts leukotriene A4 to leukotriene B4 as part of the arachidonic acid metabolism<ref>PMID:24771855</ref> . LTA4H is a bifunctional Zn+2 enzyme. | ||
- | + | == Relevance == | |
+ | LTA4H inhibitors have potential in targeting chronic, autoimmune-driven inflammation<ref>PMID:19876785</ref> . | ||
- | + | == Disease == | |
- | + | Mutations in LTA4H are linked to susceptibility to asthma and to cardiovascular disease. | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
+ | == Structural highlights == | ||
+ | LTA4H structure shows <scene name='43/433034/Cv/10'>3 domains: N-terminal, catalytic and C-terminal</scene>. The catalytic domain is made of 2 lobes: an α-helical one and an α/β one. The <scene name='43/433034/Cv/11'>catalytic site</scene> is located between the 2 lobes and <scene name='43/433034/Cv/12'>contains a Zn+2 ion</scene><ref>PMID:11175901</ref>. Water molecules shown as red spheres. | ||
+ | |||
+ | <scene name='43/433034/Cv/8'>1st Yb coordination site</scene>. | ||
+ | |||
+ | <scene name='43/433034/Cv/9'>2nd Yb coordination site</scene>. | ||
+ | </StructureSection> | ||
== 3D Structures of Leukotriene A4 Hydrolase == | == 3D Structures of Leukotriene A4 Hydrolase == | ||
- | + | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | |
- | [[ | + | {{#tree:id=OrganizedByTopic|openlevels=0| |
- | [[ | + | |
- | [[1sqm]], [[1gw6]], [[1h19]] - hLTA4H (mutant)<br /> | + | * LTA4H |
- | [[ | + | |
- | [[3ftz]], [[3ftv]], [[3ftw]], [[3ftx]], [[3fui]] - hLTA4H+aniline derivative<br /> | + | **[[4rvb]], [[5fwq]] - hLTA4H – human<br /> |
- | [[3fts]], [[3ftu]] - hLTA4H+resveratrol derivative<br /> | + | **[[1sqm]], [[1gw6]], [[1h19]] - hLTA4H (mutant) <br /> |
- | [[3fty]], [[3fu0]] - hLTA4H+pyridine derivative<br /> | + | **[[1xpy]], [[2xpy]], [[2xpz]] – yLTA4H – yeast<br /> |
- | [[3fu3]], [[3fu5]], [[3fu6]], [[3fud]] - hLTA4H+thio derivative<br /> | + | |
- | [[3fue]], [[3fuf]], [[3fuh]] - hLTA4H+bestatin+indole derivative<br /> | + | * LTA4H + inhibitor |
- | [[3fuj]], [[3fuk]] - hLTA4H+indole derivative<br /> | + | |
- | [[3b7r]], [[3cho]], [[3chp]], [[3chq]], [[3chr]], [[3chs]] - hLTA4H+inhibitor<br /> | + | **[[3fh5]], [[3fh7]], [[3fh8]], [[3fhe]], [[3ful]], [[3fum]], [[3fun]] - hLTA4H+pyrrolidine inhibitor |
- | [[3b7u]] - hLTA4H+kelatorphan<br /> | + | **[[1hs6]] - hLTA4H+bestatin<br /> |
- | [[2vj8]] - hLTA4H+hydroxamic acid<br /> | + | **[[3ftz]], [[3ftv]], [[3ftw]], [[3ftx]], [[3fui]] - hLTA4H+aniline derivative<br /> |
- | [[3b7s]], [[3b7t]] - hLTA4H (mutant)+tripeptide<br /> | + | **[[3fts]], [[3ftu]] - hLTA4H+resveratrol derivative<br /> |
- | [[ | + | **[[3fty]], [[3fu0]] - hLTA4H+pyridine derivative<br /> |
- | + | **[[3fu3]], [[3fu5]], [[3fu6]], [[3fud]] - hLTA4H+thio derivative<br /> | |
+ | **[[3fue]], [[3fuf]], [[3fuh]] - hLTA4H+bestatin+indole derivative<br /> | ||
+ | **[[3fuj]], [[3fuk]] - hLTA4H+indole derivative<br /> | ||
+ | **[[3b7r]], [[3cho]], [[3chp]], [[3chq]], [[3chr]], [[3chs]], [[2r59]], [[3u9w]], [[4r7l]], [[4rsy]], [[5aen]], [[5bpp]], [[6enc]], [[6end]], [[7auz]], [[7av0]], [[7av1]], [[7av2]], [[8ava]], [[8awh]] - hLTA4H+inhibitor<br /> | ||
+ | **[[3b7u]] - hLTA4H+kelatorphan <br /> | ||
+ | **[[2vj8]] - hLTA4H+hydroxamic acid<br /> | ||
+ | **[[4dpr]] – hLTA4H + captopril<br /> | ||
+ | **[[4ms6]], [[7kze]], [[7llq]] - hLTA4H +tripeptide analog <br /> | ||
+ | **[[4l2l]] - hLTA4H + thiazol derivative<br /> | ||
+ | **[[4mkt]] - hLTA4H +tripeptide analog + thiazol derivative<br /> | ||
+ | **[[3b7s]], [[3b7t]], [[6enb]] - hLTA4H (mutant)+tripeptide<br /> | ||
+ | **[[6o5h]] – hLTA4H + modifier<br /> | ||
+ | **[[4gaa]] - LTA4H+bestatin – frog<br /> | ||
+ | **[[2xq0]] – yLTA4H+bestatin<br /> | ||
+ | }} | ||
+ | |||
+ | == References == | ||
+ | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Current revision
|
3D Structures of Leukotriene A4 Hydrolase
Updated on 18-June-2023
References
- ↑ Paige M, Wang K, Burdick M, Park S, Cha J, Jeffery E, Sherman N, Shim YM. Role of leukotriene A4 hydrolase aminopeptidase in the pathogenesis of emphysema. J Immunol. 2014 Jun 1;192(11):5059-68. doi: 10.4049/jimmunol.1400452. Epub 2014, Apr 25. PMID:24771855 doi:http://dx.doi.org/10.4049/jimmunol.1400452
- ↑ Fourie AM. Modulation of inflammatory disease by inhibitors of leukotriene A4 hydrolase. Curr Opin Investig Drugs. 2009 Nov;10(11):1173-82. PMID:19876785
- ↑ Thunnissen MM, Nordlund P, Haeggstrom JZ. Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation. Nat Struct Biol. 2001 Feb;8(2):131-5. PMID:11175901 doi:10.1038/84117